Anal Bioanal Chem

Polybrominated diphenyl ethers (PBDEs), produced as flame retardants worldwide, have been phased-out in many countries, and chlorinated and non-chlorinated organophosphates and non-PBDE brominated formulations (e.g., Firemaster 550 (FM550)) have entered the consumers' market. Recent studies show that components of organophosphate esters and FM550 are frequently detected in many products common to human environments. Therefore, urinary metabolites of these compounds can be used as human exposure biomarkers. We developed a method to quantify\ua0nine compounds in 0.4\ua0mL urine: diphenyl phosphate (DPhP), bis(1,3-dichloro-2-propyl) phosphate (BDCPP), bis-(1-chloro-2-propyl) phosphate, bis-2-chloroethyl phosphate, di-p-cresylphosphate, di-o-cresylphosphate (DoCP), di-n-butyl phosphate, dibenzyl\ua0phosphate (DBzP), and 2,3,4,5-tetrabromobenzoic acid. The method relies on an enzymatic hydrolysis of urinary conjugates of the target analytes, automated off-line solid phase extraction, reversed phase high performance liquid chromatography separation, and isotope dilution-electrospray ionization tandem mass spectrometry detection. The method is high-throughput (96 samples/day) with detection limits ranging from 0.05 to 0.16\ua0ng\ua0mL-1. Spiked recoveries were 90-113\ua0%, and interday imprecision was 2-8\ua0%. We assessed the suitability of the method by analyzing urine samples collected from a convenience sample of adults (n\u2009=\u200976) and from a group of firefighters (n\u2009=\u2009146). DPhP (median, 0.89; range, 0.26-5.6\ua0ng\ua0mL-1) and BDCPP (median, 0.69; range, 0.31-6.8\ua0ng\ua0mL-1) were detected in all of the non-occupationally exposed adult samples and all of the firefighter samples (DPhP [median, 2.9; range, 0.24-28\ua0ng\ua0mL-1], BDCPP [median, 3.4; range, 0.30-44\ua0ng\ua0mL-1]); DBzP and DoCP were not detected in any samples.CC999999/Intramural CDC HHS/United States2018-02-01T00:00:00Z27838756PMC5576356vault:2447